Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.

Doria, Carlo; Leali, Paolo Tranquilli; Solla, Federico; Maestretti, Gianluca; Balsano, Massimo; Scarpa, Robero Mario

Doria, Carlo; Leali, Paolo Tranquilli; Solla, Federico; Maestretti, Gianluca; Balsano, Massimo; Scarpa, Robero Mario.

Afiliação

Doria C; Orthopaedic Department, University of Sassari, Italy.
Leali PT; Orthopaedic Department, University of Sassari, Italy.
Solla F; Orthopaedic Department, Paediatric Hospital Nice CHU-Lenval, France.
Maestretti G; Spinal Unit - Cantonal Hospital Fribourg, Switzerland.
Balsano M; Orthopaedic Department, Santorso Hospital AUSSL 4 Schio, Italy.
Scarpa RM; University of Turin, Italy.

Clin Cases Miner Bone Metab ; 13(3): 195-199, 2016.

Article em En | MEDLINE | ID: mdl-28228781

Palavras-chave

Bone Mineral Density; denosumab; hypogonadism; osteoporosis; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cases Miner Bone Metab Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google